Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
Shares of one of ChemoCentrix (SYM: CCXI) are up $26 today after Amgen agreed to buy the company for $4 billion in cash. The stock is selling for $50.13. 
For now, I'm advising we take some profits and sell half of our position. More updates to come. 

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
Shares of one of ChemoCentrix (SYM: CCXI) are up $26 today after Amgen agreed to buy the company for $4 billion in cash. The stock is selling for $50.13. 
For now, I'm advising we take some profits and sell half of our position. More updates to come. 

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.